SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-21-016681
Filing Date
2021-05-11
Accepted
2021-05-10 18:22:45
Documents
2
Group Members
THL EQUITY ADVISORS VI (2019), LLCTHL EQUITY ADVISORS VII, LLCTHL EQUITY FUND VII INVESTORS (INVENTIV), L.P.THL EXECUTIVE FUND VII, L.P.THL FUND VI (2019) COINVESTMENT PARTNERS, L.P.THL FUND VII COINVESTMENT PARTNERS, L.P.THL HOLDCO LLCTHL MANAGERS VI, LL

Document Format Files

Seq Description Document Type Size
1 SC 13DA brhc10024328_sc13da.htm SC 13D/A 500300
2 EXHIBIT 99.16 brhc10024328_ex99-16.htm EX-99.16 33072
  Complete submission text file 0001140361-21-016681.txt   535836
Mailing Address C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110
Business Address C/O THOMAS H. LEE PARTNERS, L.P. 100 FEDERAL STREET, 35TH FLOOR BOSTON MA 02110 6172271050
THOMAS H. LEE ADVISORS, LLC (Filed by) CIK: 0001260943 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1030 SYNC STREET MORRISVILLE NC 27560
Business Address 1030 SYNC STREET MORRISVILLE NC 27560 919-876-9300
Syneos Health, Inc. (Subject) CIK: 0001610950 (see all company filings)

IRS No.: 273403111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88633 | Film No.: 21908923
SIC: 8731 Services-Commercial Physical & Biological Research